0
0
Read Time:9 Second
Biocon Limited has informed the Exchange regarding a press release dated July 07, 2025, titled “Biocon Biologics Receives MHRA UK Approval for Vevzuo® and Evfraxy®, Denosumab Biosimilars”. |SUBJECT: Press Release
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
